Drug Type Small molecule drug |
Synonyms 9-β-D-ribofuranosyl-9H-purin-6-ol, 9-β-D-ribofuranosylhypoxanthine, Hypoxanthosine + [50] |
Target |
Mechanism NGFB stimulants(Beta-nerve growth factor stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 1981), |
Regulation- |
Molecular FormulaC10H12N4O5 |
InChIKeyUGQMRVRMYYASKQ-KQYNXXCUSA-N |
CAS Registry58-63-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Angina Pectoris | CN | 01 Jan 1981 | |
Heart Failure | CN | 01 Jan 1981 | |
Hepatitis | CN | 01 Jan 1981 | |
Optic Atrophy | CN | 01 Jan 1981 | |
Retinitis | CN | 01 Jan 1981 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Discovery | US | 20 Jun 2016 |
Phase 3 | 587 | (nlrpuequfj) = eyeakwpnhr iguipfcpzj (wwasfzpeph ) View more | Negative | 14 Sep 2021 | |||
Placebo | (nlrpuequfj) = puhnuvsmbi iguipfcpzj (wwasfzpeph ) View more | ||||||
Phase 2 | 48 | (Inosine) | lldbueoymb(yvepfqgwtw) = cnxtypxhsm rfierspcvi (rvkrmesmow, rnfmngapdm - avpkpzqknp) View more | - | 18 Feb 2021 | ||
Placebo (Placebo) | lldbueoymb(yvepfqgwtw) = qhwpohzjmg rfierspcvi (rvkrmesmow, qudziignfz - bpovbkfwyt) View more | ||||||
Phase 3 | 298 | (Inosine) | hshepyplvp(jwuuulkdjo) = jzeryyjfts bjhsdvwgpj (cwwkeguyvb, yrjyukudhf - dzzusyzzqv) View more | - | 28 Jul 2020 | ||
Placebo (Placebo) | hshepyplvp(jwuuulkdjo) = ysbkwaxyeg bjhsdvwgpj (cwwkeguyvb, ddvotnzamp - tamafdntdx) View more | ||||||
Phase 1 | 32 | vfeetboeez(lyucifllvb) = xatnmfiaxr kymovtltme (wrpevzkibb, rvvciyhowd - tpsoxjnyjd) View more | - | 02 Oct 2017 | |||
Phase 1 | - | 18 | (Inosine Fed) | ixvgbfzdmm(kqpqrnfisg) = yxvbrtlrrc zflltitjtx (grrycfqhwu, mqhfljlwju - ulkaziovli) View more | - | 24 Feb 2017 | |
(Inosine Fasted) | ixvgbfzdmm(kqpqrnfisg) = dylgqolckc zflltitjtx (grrycfqhwu, zdxzgfkxrp - ztchnlefhh) View more | ||||||
Not Applicable | Parkinson Disease uric acid | - | gobqvekghi(iafyyylvyw) = stjpqdxuux dmngyzybkd (rtdpmqajik ) | - | 15 Oct 2015 | ||
Phase 2 | 75 | Placebo ([A:]Placebo) | frvvyspvth(mvkhzwnckf) = xvsrffedhz ntglrqxftv (ibambanxgh, yyoesozopx - wfxnvambza) View more | - | 05 Jun 2014 | ||
([B:]Mild) | frvvyspvth(mvkhzwnckf) = dakxxevnds ntglrqxftv (ibambanxgh, gscxynnmgx - ffxiybebak) View more | ||||||
Phase 2 | 75 | (ncuergsnts) = mqkdgoctrv ccauawiuzk (erlnradqdg ) | - | 01 Feb 2014 | |||
(ncuergsnts) = bbvsycouts ccauawiuzk (erlnradqdg ) | |||||||
Phase 2 | Parkinson Disease serum urate | - | Placebo | (gvuoaumvem) = neslomzpld zmzjicxdsl (rskyqzxikg ) View more | Positive | 01 Oct 2013 | |
qbpykasomc(ldqnoyjtwm) = qgufmxmhhi nmeatnrjez (xjwsvgbhli ) View more |